FIU Professor's Math Model Revolutionizes Lung Cancer Screening for Earlier Cures in Cutler Bay

A new mathematical model developed by Florida International University math professor Deborah Goldwasser could significantly improve how doctors screen for aggressive lung cancers, potentially leading to earlier detection and higher cure rates for Cutler Bay residents and beyond.

Goldwasser's research focuses on identifying what she calls the 'cure threshold' for aggressive lung cancers. This threshold represents the critical point where a cancer is still curable through surgical removal before it becomes inoperable. Her work aims to correct statistical biases in older models that may have overestimated the curable window for these fast-growing cancers.

The study, published in Cancer Epidemiology, Biomarkers & Prevention, a flagship journal of the American Association for Cancer Research, highlights the limitations of previous models. Earlier estimates of lung cancer progression and curability relied heavily on chest X-rays and cancer registry data. However, the advent of newer, more sensitive low-dose CT (LDCT) scans provides a much clearer picture.

LDCT scans detect smaller, faster-growing tumors at earlier stages than traditional methods predicted, especially during annual screenings. Goldwasser's model accounts for this improved detection capability, offering more accurate estimates of how long aggressive cancers remain curable. This is crucial because current lung cancer screening guidelines primarily focus on determining if a lung nodule is cancerous, often overlooking this vital 'cure threshold'.

Goldwasser emphasized the importance of this distinction. "If every lethal cancer you detect before the cure threshold is contributing to mortality reduction, that’s where you’re getting a benefit of screening," she stated. Once a tumor progresses beyond this point, the effectiveness of screening in improving survival significantly diminishes.

Her research suggests that by incorporating this mathematical understanding, screening protocols can be refined to maximize the benefit of early detection, ultimately reducing mortality from lung cancer.